loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for DSSTox_CID_28994

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    DSSTox_CID_28994

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,929Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Antiseizure Drug DIACOMIT Now Approved for Children as Young as 6 Months
    Antiseizure Drug DIACOMIT Now Approved for Children as Young as 6 Months

    21 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/antiseizure-drug-diacomit-now-approved-for-children-as-young-as-6-months-301628988.html

    PRNEWSWIRE
    21 Sep 2022
    Share Share
    PANTHERx Rare Announces Partnership with Biocodex for Distribution of DIACOMIT
    PANTHERx Rare Announces Partnership with Biocodex for Distribution of DIACOMIT

    27 Jun 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/pantherx-rare-announces-partnership-with-biocodex-for-the-distribution-of-diacomit-stiripentol-for-the-treatment-of-seizures-associated-with-dravet-syndrome-in-patients-2-years-of-age-and-older-taking-clobazam-301575862.html

    PRNEWSWIRE
    27 Jun 2022
    Share Share
    M8 Pharmaceuticals Bags License of Exclusive rights for Diacomit from Biocodex
    M8 Pharmaceuticals Bags License of Exclusive rights for Diacomit from Biocodex

    14 Sep 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/m8-pharmaceuticals-announces-license-of-exclusive-rights-for-diacomit-stiripentol-from-biocodex-sas-301376198.html

    PRNEWSWIRE
    14 Sep 2021
    Share Share
    Zogenix Ready to Resubmit Fintepla for Rare Epilepsy to FDA
    Zogenix Ready to Resubmit Fintepla for Rare Epilepsy to FDA

    27 Jun 2019

    // Mark Terry BIOSPACE

    https://www.biospace.com/article/zogenix-given-go-ahead-to-resubmit-fintepla-to-fda-for-dravet-syndrome/

    Mark Terry BIOSPACE
    27 Jun 2019
    Share Share
    Encoded Therapeutics bags $104M to propel 'precision gene therapy’
    Encoded Therapeutics bags $104M to propel 'precision gene therapy’

    26 Jun 2019

    // Amirah Al Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/encoded-therapeutics-bags-104m-to-propel-precision-gene-therapy-for-dravet-syndrome

    Amirah Al Idrus FIERCE BIOTECH
    26 Jun 2019
    Share Share
    2018 Drug Approvals: A Closer Look
    2018 Drug Approvals: A Closer Look

    05 Feb 2019

    // Derek Lowe SCIENCE MAG BLOG

    https://blogs.sciencemag.org/pipeline/archives/2019/02/04/2018-drug-approvals-a-closer-look?r3f_986=https://www.google.com/

    Derek Lowe SCIENCE MAG BLOG
    05 Feb 2019
    Share Share